The effects of zinc supplementation on inflammatory parameters in pregnant women with impaired glucose tolerance: A randomized placebo controlled clinical trial

Progress in Nutrition

Volumn 20, Issue , 2018, Pages 330-336

  Roshanravan, Neda ^a   Tarighat Esfanjani, Ali ^b   Alamdari, Naimeh Mesri ^c   Kheirouri, Sorayya ^b   Mousavi, Reihaneh ^d   Alizadeh, Mohammad ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gestational Diabetes Mellitus; Interleukin 6; Pregnancy; Vaspin; Zinc

Indexed keywords

GLUCONATE ZINC; INSULIN; INTERLEUKIN 6; VASPIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FASTING; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN TREATMENT; IRAN; MINERAL SUPPLEMENTATION; PARAMETERS; PREGNANT WOMAN; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL;

EID: 85053030569     PISSN: 11298723     EISSN: None     Source Type: Journal    
DOI: 10.23751/pn.v20i1-S.5867     Document Type: Article

References (36)

1. Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care 2010; 33(Supplement 1): S62-9.
2. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RPV. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol 2013; 209(1): 34.e1-7.
3. Lobo TF, Torloni MR, Gueuvoghlanian-Silva BY, Mattar R, Daher S. Resistin concentration and gestational diabetes: A systematic review of the literature. J Reprod Immunol 2013; 97(1): 120-7.
4. Pan J, Zhang F, Zhang L, Bao Y, Tao M, Jia W. Influence of insulin sensitivity and secretion on glycated albumin and hemoglobin A1c in pregnant women with gestational diabetes mellitus. Int J Gynaecol Obstet 2013; 121(3): 252-6.
5. Lopez-Tinoco C, Roca M, Fernandez-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 2012; 58(1): 14-9.
6. Gkiomisi A, Makedou KG, Anastasilakis AD, et al. Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum. Cytokine 2013; 61(1): 127-32.
7. Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol 2012; 76(1): 2-11.
8. Richardson AC, Carpenter MW. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am 2007; 34(2): 213-24.
9. Black PH. The inflammatory consequences of psychologic stress: Relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 2006; 67(4): 879-91.
10. Aust G, Richter O, Rohm S, et al. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009; 204(1): 262-6.
11. Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 2005; 102(30): 10610-5.
12. Caminos JE, Bravo SB, Garces MF, et al. Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status. Histol Histopathol 2009; 24(8): 979-90.
13. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14(11-12): 741.
14. Kim H-J, Higashimori T, Park S-Y, et al. Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004; 53(4): 1060-7.
15. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278(46): 45777-84.
16. Morisset As, Dube Mc, Cote Ja, Robitaille J, Weisnagel S, Tchernof A. Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand 2011; 90(5): 524-30.
17. Foster M, Samman S. Zinc and regulation of inflammatory cytokines: Implications for cardiometabolic disease. Nutrients 2012; 4(7): 676-94.
18. Vashum KP, McEvoy M, Shi Z, et al. Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women's health. BMC Endocr Disord 2013; 13(1): 40.
19. Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009; 160(1): 65-70.
20. Prevention I, Type Do. Standards of medical care in diabetes- 2011. Diabetes care 2011; 34: S11.
21. Argani H, Mahdavi R, Ghorbani-haghjo A, et al. Effects of zinc supplementation on serum zinc and leptin levels, BMI, and body composition in hemodialysis patients. J Trace Elem Med Biol 2014;28(1):35-8.
22. Wiernsperger N, Rapin J. Trace elements in glucometabolic disorders: An update. Diabetol Metab Syndr 2010; 2(70): 1-9.
23. Sun Q, Van Dam RM, Willett WC, Hu FB. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes care 2009; 32(4): 629-34.
24. Konukoglu D, Turhan MS, Ercan M, Serin O. Relationship between plasma leptin and zinc levels and the effect of insulin and oxidative stress on leptin levels in obese diabetic patients. J Nutr Biochem 2004; 15(12): 757-60.
25. Hossein-Nezhad A, Maghbooli Z, Vassigh A-R, Larijani B. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol 2007; 46(3): 236-41.
26. Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: A population-based study in southern Sweden. Am J Obstet Gynecol 2001; 184(2): 77-83.
27. Wang C. Obesity, Inflammation, and Lung Injury (OILI): The Good. Mediators Inflamm 2014; 2014: 978463.
28. Choi SH, Hong ES, Lim S. Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front Endocrinol (Lausanne) 2013; 4: 97.
29. Stepan H, Kralisch S, Klostermann K, Schrey S, Reisenbuchler C, Verlohren M, et al. Preliminary report: Circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010; 59(7): 1054-6.
30. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11(2): 85-97.
31. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus the insulin and cytokine network. Diabetes care 2007; 30(Supplement 2): S120-6.
32. Kim J, Ahn J. Effect of zinc supplementation on inflammatory markers and adipokines in young obese women. Biol Trace Elem Res 2014; 157(2): 101-6.
33. Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW, et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: A potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 2010; 91(6): 1634-41.
34. Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM. Diverse effects of zinc on NF-κB and AP-1 transcription factors: Implications for prostate cancer progression. Carcinogenesis 2006; 27(10): 1980-90.
35. Mariani E, Cattini L, Neri S, Malavolta M, Mocchegiani E, Ravaglia G, et al. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: Relationship with zinc status. Biogerontology 2006; 7(5-6): 449-59.
36. Mocchegiani E, Giacconi R, Costarelli L, Muti E, Cipriano C, Tesei S, et al. Zinc deficiency and IL-6- 174G/C polymorphism in old people from different European countries: Effect of zinc supplementation. ZINCAGE study. Exp Gerontol 2008; 43(5): 433-44.